Journal of Psychiatric Research
May 26, 2025
Bjørn Holmøy, Tor-Morten Kvam, Kristoffer Andreas Aamodt Andersen et al.
3 citations
Psychedelic drugs, known for their potent psychoactive effects, have gained attention for their potential therapeutic benefits in treating mental disorders. However, distressing experiences induced by psychedelics can lead to adverse long-term effects. To better assess these experiences, we aimed to provide a Norwegian translation and psychometric validation of the Challenging Experience...
Contribuciones a las Ciencias Sociales
May 21, 2025
Rodrigo Vitorino Gonçalves, Monica Montemor Bertazo, José Claudio Pereira da Silva et al.
O uso terapêutico de psicodélicos tem ganhado crescente interesse na psiquiatria, principalmente no tratamento de transtornos mentais resistentes a terapias convencionais, como a depressão resistente e a ansiedade. Este artigo de revisão aborda os fundamentos bioquímicos, a segurança e as indicações emergentes de psicodélicos, como ayahuasca, DMT, psilocibina e LSD, com foco nos mecanismos...
Journal of Psychedelic Studies
May 17, 2025
Daria Dikovskaya, Bhargav Srinivasa Desikan, Joel Frohlich et al.
2 citations
Abstract Background and aims Altered states of consciousness (ASC) represent acute and marked deviations from normal waking consciousness. Investigations into ASC are significant to problems in medicine, science, and philosophy, including the structure of conscious experience. Here, we conducted a preliminary investigation into the structure of ASC while addressing the role of psychedelics,...
Healthcare
May 16, 2025
Sean Matthew Viña
5 citations
Background: Structural inequalities in healthcare access may influence how individuals experience the psychological effects of psychedelic substances, potentially limiting positive outcomes among vulnerable populations. Objectives: This study uses data from the National Survey on Drug Use and Health (2008–2019; N = 484,732) to examine how public and private health insurance moderate the...
ACS Pharmacology & Translational Science
May 15, 2025
Haojiang Zhai, Hongshuang Wang, Haohong Li et al.
3 citations
The interplay between psychedelics, such as psilocybin, lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT), and sleep is an emerging area, but their impact on sleep remains relatively underexplored. This viewpoint provides a perspective on how psychedelics may alter sleep phases, dreaming, and their potential therapeutic applications for sleep disorders.
Frontiers in Psychology
May 15, 2025
Jake Hooper, Emily L Gyongyosi, Kent E. Hutchison et al.
5 citations
Introduction The aesthetic qualities of psychedelic experiences have long been documented, but their specific contribution to therapeutic outcomes remains understudied. Aesthetic experiences may facilitate emotional breakthroughs and cognitive shifts, potentially playing a crucial role in the lasting psychological benefits observed following psychedelic use. Methods This cross-sectional study...
May 14, 2025
Michael D. Cole, Lata Gautam, Agatha Grela
1 citation
This chapter introduces drugs derived from plants and fungi including lysergic acid diethylamide (LSD), psilocybin (from ‘magic mushrooms’), N,N-dimethyltryptamine (DMT) and mescaline. Their physical description and chemical identification are described. The use of fluorescence detection for HPLC analysis of drugs and the greater selectivity it offers over UV and diode array detection are...
Neuroscience & Biobehavioral Reviews
May 9, 2025
Rotem Petranker, Benjamin Tsang, Omer A. Syed
3 citations
Microdosing, the repeated use of psychedelic substances at low doses, is growing in popularity among recreational consumers. While this practice is associated with many benefits to mood, well-being and health, research in this area is in its early stages and predominantly centered on human applications. In this narrative review, we synthesize the findings from studies investigating the effects...
American Journal of Psychotherapy
May 6, 2025
David A Bender, Sandeep M. Nayak, Joshua S. Siegel et al.
7 citations
Psychedelic therapies are promising new treatment options in psychiatry. Including the use of physical touch as part of treatment is an area of debate. This study aimed to characterize the viewpoints of practitioners on the use of touch in psychedelic therapy. An anonymous survey was distributed via e-mail to the contacts listed on ClinicalTrials.gov for trials of psilocybin and lysergic acid...
Alcoholism Treatment Quarterly
May 2, 2025
Ritika Shah, Ashish Sarangi
ABSTRACT Background Alcohol Use Disorder (AUD) is a widespread condition with serious health, social, and economic impacts, often marked by relapse despite the availability of FDA-approved treatments. Recent studies suggest that psychedelic substances, such as psilocybin, Lysergic acid diethylamide (LSD), ayahuasca, etc. may offer novel therapeutic potential in treating AUD by modulating...